Clinical Emerging Investigator
Clinical Emerging Investigator
The application guidelines are from 2021 – will be updated before the next application round opens!
To support and strengthen the development of young and promising clinical research leaders and promote Danish clinical and translational research at a high international level, the Novo Nordisk Foundation seeks to support the starting clinical research leaders with ambitions of combining their clinical work with clinically relevant research.
The project must be a 5-year project and it must be anchored at a Danish university, hospital or other non-profit research institution.
- It is essential, that applicant’s own salary must be covered throughout the entire 5-year project period.
- Applicants must have an MD and should have a Ph.D., a dr. med. or similar qualifications.
- Applicants must either be ready to start, be under, or have just finished their medical specialist training (applicants may not be more than two years post-completion of their medical specialist training). I.e. KBU and the introductory position must be completed if applicants are not yet under medical specialist training.
- Applicants must commit to minimum 20% (1 workday) and maximum 60% (3 workdays) research time, leaving from 80% (4 workdays) to 40% (2 workdays) to clinical work at a Danish hospital. The amount of time dedicated to research and clinical work can vary over the five project years, as it best fits the project and applicant.
- Applicants must have institutional support from the heads of both the clinical department and the department where the research is to be performed (hosting and support letters must be uploaded to the application, please see section 3.4 for further information).
- Upon granting, it is the applicant’s responsibility to establish an agreement with the regional council on postgraduate medical training for their individual case.
- ‘Clinical Emerging Investigator’ grants are individual grants at the disposal of the applicant. If the applied project involves collaboration, the collaboration and the nature of the collaboration should be described in the project description, but the applicant must be the clear driver of the project (it is not possible to have or register co-applicants for this specific call).
The overall goal is to support medical research with relevance to patients and human health. The research fields could be within, but are not limited to: Patients and disease related research, translational and clinical research, research in: disease mechanisms; treatment methods; disease trajectories, epidemiology; diagnostic methods; public health and family medicine, intervention studies, register-based research, proof-of concept studies, pilot projects, initial clinical trials and clinical testing, biomedicine etc.
The 5-year grant amounts up to DKK 10 million, depending on the time spend / level of commitment from the applicant to the research project.
Up to four Investigator Grants can be awarded in 2021.
The application must be completed and submitted using the foundation’s electronic application system, using the link “Apply”. Link is found at the top of the page and will be visible when the call opens.
It is very important, that the applicant carefully reads the ‘Guidelines for applicants – Clinical Emerging Investigator 2021’, before initiating the application process. This document contains the complete call as well as detailed instructions for the application process.
Selected applicants will be invited for an interview on March 19, 2021 (applicants will be notified in the beginning of March 2021).